CPT Code Overview

CPT code 81409 is used for drug metabolism genotyping panels, which must include analysis of the 2D6, 2C19, and 2C9 genes by any method. This laboratory service is typically performed in an independent laboratory setting (Place of Service 81). Drug metabolism genotyping is essential for understanding how patients process various medications, enabling more personalized and effective treatment plans.

Clinical Context

A patient is referred to an independent laboratory for drug metabolism genotyping. The ordering provider, such as a family medicine physician, internal medicine physician, or clinical pathologist, seeks to determine how the patient metabolizes certain medications. This is particularly relevant for patients who require therapeutic drug level monitoring, are on long-term drug therapy, or are being screened for genetic and chromosomal anomalies. The laboratory performs a genotyping panel that includes analysis of the CYP2D6, CYP2C19, and CYP2C9 genes, which are critical for drug metabolism. Results inform medication selection and dosing, especially for drugs metabolized by these enzymes. The workflow involves specimen collection, laboratory analysis, and reporting of results to the provider for clinical interpretation.

Coding Specifications

• Modifiers:

  • Modifier 26: Used when billing for the professional component of the laboratory service, such as interpretation of results by a physician or pathologist.
  • Modifier TC: Used when billing for the technical component, which includes specimen processing and laboratory analysis.

• Provider Taxonomies:

  Code	Specialty
  207Q00000X	Family Medicine Physician
  207R00000X	Internal Medicine Physician
  207ZP0102X	Clinical Pathologist
  291U00000X	Clinical Laboratory

These taxonomies represent the types of providers and facilities typically involved in ordering, performing, and interpreting drug metabolism genotyping panels.

Related Diagnoses

• Z13.79 - Encounter for other screening for genetic and chromosomal anomalies

  • Relevant for patients undergoing genetic screening to assess drug metabolism potential.

• Z51.81 - Encounter for therapeutic drug level monitoring

  • Used when monitoring drug levels to optimize therapy based on genetic metabolism.

• R79.89 - Other specified abnormal findings of blood chemistry

  • Applied when abnormal blood chemistry findings prompt further genetic investigation.

• Z79.899 - Other long term (current) drug therapy

  • Indicates patients on long-term drug therapy where genotyping may inform medication management.

• Z00.6 - Encounter for examination for normal comparison and control in clinical research program

  • Used in clinical research settings where genotyping is performed for comparison or control purposes.

Related CPT Codes

• 81225 - CYP2C19 gene analysis: Used for individual analysis of the CYP2C19 gene. This code may be used when only CYP2C19 genotyping is required, rather than a panel.

• 81226 - CYP2D6 gene analysis: Used for individual analysis of the CYP2D6 gene. This code may be used separately if only CYP2D6 genotyping is needed.

• 81227 - CYP2C9 gene analysis: Used for individual analysis of the CYP2C9 gene. This code may be used when only CYP2C9 genotyping is performed.

• 81408 - Molecular pathology procedure, Level 9: Represents a high-complexity molecular pathology procedure. It may be used for more extensive or complex genetic testing beyond the standard panel.

• 81479 - Unlisted molecular pathology procedure: Used when a molecular pathology procedure does not have a specific CPT code. It may be used for unique or uncommon genotyping panels.

Codes 81225, 81226, and 81227 are commonly used as alternatives to the panel code 81409 when only one or two genes are tested. Codes 81408 and 81479 may be used for more complex or unlisted procedures.

For CPT code 81409, the national mean rate for Blue Cross Blue Shield and BUCA (average commercial) is $80.02. Medicare rates are not available in the input for this code, so a comparison between commercial and Medicare rates cannot be made.

Rate dispersion across payers is minimal, with the 25th, 50th, and 75th percentiles all at $80.00 for both Blue Cross Blue Shield and BUCA. This indicates a very tight range, with no variation between the lower and upper quartiles. The table and chart below present the full breakdown of national payer benchmarks for CPT code 81409.